Veracyte Inc logo

VCYT - Veracyte Inc News Story

$46.91 -8.5  -15.3%

Last Trade - 04/03/21

Sector
Healthcare
Size
Mid Cap
Market Cap £2.26bn
Enterprise Value £2.01bn
Revenue £84.6m
Position in Universe 1752nd / 6647

BRIEF-Veracyte Announces De Novo Classification Request To FDA For The Ncounter Dx Lymphmark Assay

Tue 9th June, 2020 1:24pm
June 9 (Reuters) - Veracyte Inc  VCYT.O :
    * VERACYTE ANNOUNCES DE NOVO CLASSIFICATION REQUEST TO FDA
FOR THE
NCOUNTER DX LYMPHMARK ASSAY

Source text for Eikon:  ID:nBw1mNJZka 
Further company coverage:  VCYT.O 

 ((Reuters Messaging: Reuters.Briefs@thomsonreuters.com))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.